VEGFA and glioblastoma: Notably, SF3B1 blockade induced marked reductions in aggressiveness features of different GBM cell models [cell -lines and primary-GBM cell -cultures, i.e., inhibition of proliferation/migration/VEGF secretion, and increase of apoptosis].